Record revenue, margin sustains amid integration costs
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Reaffirmed 23%–24% Sahyadri margin target (4–5 yr); greenfield bed additions tracking guidance. No FY27 PAT guidance given; avoided over-commitment.
Optimistic
next 1–2 quarters
Optimistic
multi-year
Manipal delivered record revenue (₹3,399 Cr, +37% YoY) with stable 23% OPM and +17% PAT growth—solid operational execution and digital monetization (23% of revenue). However, greenfield/integration costs (Electronic City ₹13 Cr Q2 loss, Gurugram ramp) and government-scheme volatility will suppress near-term upside. Sahyadri is ahead of 4–5 yr margin target, validating expansion thesis, but capex cycle requires 2–3 yr patience.
₹3399.3 Cr
Revenue · +37% YoY₹285 Cr
Reported PAT · +null% YoYExpanding
Margins · vs guidance: CorroboratedDid the claims hold up?
Q2 revenue of INR3,400 Cr, 37% YoY growth
METDelivered ₹3,399.3 Cr; claim matches reported, YoY % not independently verified but consistent with management narrative
Q2 EBITDA INR882 Cr at 26% margin incl. Sahyadri
METIf EBITDA 882 on 3399.3 revenue, margin = 25.9% ≈ 26%, consistent
Q2 PAT INR639 Cr, 10% margin
OVERSTATEDDelivered Q2 PAT ₹285.0 Cr (8.1% margin). Statement in opening remarks likely referred to H1, not Q2 alone.
Volume-led growth: inpatient +35% YoY, outpatient +27% YoY
METOccupancy rose 65% → 70% QoQ, 2.8 days LOS, ARPOB ₹70.6K/day—strong operational metrics align with claim
Sahyadri Q2 revenue INR375 Cr, 13% sequential growth
METSahyadri EBITDA ₹73 Cr, 19.5% margin Q2—improvement over 15.5% FY26, greenfields at 24%–25% already
Earnings quality
What changed since the last call
Greenfield execution timeline extended
DowngradeElectronic City ramp slower than anticipated; ₹13 Cr EBITDA loss Q2 vs prior expectation of quicker breakeven. Gurugram now 3–4 yr plan vs initially suggested nearer term.
Digital revenue momentum sustained
UpgradeDigital now 23% of H1 revenue (from prior <15% implied); e-pharmacy 34k orders/qtr, telehealth 38k consultations/qtr.
Sahyadri margin trajectory ahead of curve
UpgradeGreenfields Kanakapura & Yelahanka already at 24%–25% EBITDA margin <1 yr post-launch; exceeds 4–5 yr guidance.
Occupancy and volume inflection confirmed
UpgradeOccupancy 65% → 70% QoQ; inpatient +35% YoY, outpatient +27% YoY; ARPOB ₹70.6k/day (+8% YoY).
The Q&A
Analysts pressed hard on Electronic City losses, Sahyadri rate negotiations, government scheme headwind duration, and Tier 2/3 capex ROI. Management held firm on strategic vision, acknowledged costs, but declined to quantify H2/FY28 upside; emphasised 4–5 yr horizon. Tone: confident on fundamentals, cautious on near-term.
East India cluster performance — Damayanti Kerai, HSBC
AnsweredScheme transition (Swasthya Sathi) created headwind, but revenue robust. Cash & TPA focus ongoing. Dhakuria new oncology team onboarded; expect recovery as clinicians settle.
Oncology exposure & drug capping — Aman Goyal, IIFL Capital
PartialOnco revenue ~12% of network. Drug capping is small portion of that (controlled drugs). No material impact at scale.
Electronic City EBITDA loss — Aman Goyal, IIFL Capital
PartialRamp-up phase. Multi-pronged approach: complexity of work, high-end programs, clinicians adding. Trajectory improving; loss not structural.
Bed addition timeline & capex — Karan Vora, Goldman Sachs
AnsweredH2 ~440–550 beds (greenfield + brownfield). Kinder 100 beds end-Q2. FY28 ~100 beds brownfield. Capex fully invested.
Sahyadri margin trajectory — Neha Manpuria, Bank of America
AnsweredReaffirming 23%–24% over 4–5 yr. Teams joining, digital ramping 11%, operating efficiencies. No specific timing on 25%.
Payer mix: Tier 2/3 govt. prevalence — Kunal Randeria, Axis Capital
AnsweredComfortable in 80% range. Focus on cash, TPA, desirable payer mix. Govt. business improving selectively.
Greenfield strategy: Bangalore vs Mumbai/Raipur — Alankar Garude, Kotak Institutional Equities
AnsweredBangalore: densified, micro-market. Mumbai/Raipur: larger footprint, staggered approach. Teams & doc availability different.
Geographic diversification rationale — Aman Kumar Singh, Individual
AnsweredManipal originated in Karnataka 35 yr ago; natural home-market strength. Expanding South, West, East. Focused on tertiary/quaternary care only.
Guidance
FY27–FY28: 1,000+ new beds ramp Q2–Q4 FY27 onwards
MediumH2 FY27 ~440–550 beds; FY28 ~100 brownfield. Greenfields (Kanakapura, Yelahanka, Electronics City) show ramp, though timeline extended vs prior expectation.
Sahyadri: 23%–24% EBITDA margin over 4–5 yr from acquisition
HighAlready at 19.5% Q2; greenfields at 24%–25% <1 yr. Guidance ahead of curve, being beaten on early ramp.
Portfolio: progressing toward 25% EBITDA margin
MediumCurrently 26% (Q2 incl. Sahyadri). Digital revenue now 23% will help; greenfield losses (Electronic City) temporary headwind.
FY27: ₹2,000 Cr capex (from Q1 implicit); FY28–FY30: ₹4,000 Cr for 3,000-bed capacity
MediumMajor spends: Gurugram, Gurudwara, Raipur, Mumbai new sites. Debt repaid ₹500+ Cr Q2; capex cycle now ramping.
Risks the call surfaced
Greenfield execution
MediumElectronic City ₹13 Cr Q2 EBITDA loss; Gurugram, Kinder still in ramp. Complexity & clinician availability in new markets delaying margins 1–2 yr beyond initial plan.
Government scheme volatility
MediumEast India Swasthya Sathi reduction; Ayushman Bharat scheme instability. Govt. business 13%–14% of mix; scheme changes create margin/volume noise quarterly.
Sahyadri integration & insurance
MediumSahyadri Hospitals Private Limited remains separate entity post-acquisition; insurance contracts need renegotiation (legal entity unchanged). Rate pressures in Pune if entity rebrand happens.
Occupancy and payer mix in Tier 2/3
MediumRaipur, Mumbai, new greenfields require 2–3 yr to reach 70%+ occupancy. Clinician talent constraints in non-Bangalore metros. Government scheme unpredictability in Tier 2/3.
Capex & debt burden
Low₹2,000 Cr FY27 capex + ₹4,000 Cr over 3–4 yr plan is capital-intensive. Debt repaid ₹500 Cr Q2, but interest costs remain until maturity. Refinance risk if rates stay elevated.
Management
Score 7/10. Clear on operational metrics (occupancy, volumes, ARPOB), specific on segment performance (Sahyadri 19.5%, greenfields 24%–25%). Transparent on challenges (Electronic City loss, scheme volatility). Cautious on forward guidance (no FY27/FY28 PAT target given) to avoid over-commitment. Track record mixed. Bed addition targets broadly on track but slower than anticipated (Electronic City ramp extended). Sahyadri margin trajectory ahead of 4–5 yr target. Digital revenue momentum (23% of H1) exceeding expectations. Greenfield complexity & capex cycle stretching timeline.
1 · H2 FY27
Electronic City, Gurugram, Kinder Hotel ramp; 440–550 bed add-ons
2 · FY28 start
Sahyadri insurance rate negotiations finalize; greenfield breakeven visibility
3 · FY28–FY29
Gurugram 500-bed tertiary facility onstream; digital monetization scaling
Sahyadri is ahead of 4–5 yr margin target, validating expansion thesis, but capex cycle requires 2–3 yr patience.
Informational and educational content only. Not investment advice.